Krystal Biotech, Inc. (KRYS) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Join SI Premium – FREE
Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q2 EPS of ($1.25), $0.02 better than the analyst estimate of ($1.27).
For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Innovaro (INV) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
